参考文献/References:
[1] 孟宝,伍婷,苏丛,等.肠道菌群参与细菌性肺炎的免疫调控研究进展[J].中华传染病杂志,2022,40(3):181-184.
MENG B,WU T,SU C,et al.Research progress of intestinal flora involved in immune regulation of bacterial pneumonia[J].Chin J Infect,2022,40(3):181-184.
[2] 罗云.细菌感染性肺炎患儿血清PCT、hs-CRP、WBC、IL-6、Hb与病情严重程度的相关性分析[J].武警医学,2022,33(4):277-280,286.
LUO Y.Correlation analysis of serum PCT,Hs-CRP,WBC,IL-6,Hb and disease severity in children with bacterial infection pneumonia[J].Med J Chin PAP,2022,33(4):277-280,286.
[3] ZASOWSKI E J,BASSETTI M,BLASI F,et al.A systematic review of the effect of delayed appropriate antib-i otic treatment on the outcomes of patients with severe bacterial infections[J].Chest,2020,158(3):929-938.
[4] 刘湛.降钙素原、C反应蛋白、未成熟粒细胞联合检测对肺部早期细菌性感染的诊断价值[J].河南医学研究,2021,30(6):1122-1124.
LIU Z.Combined detection of procalcitonin,C-reactive protein and immature granulocytes diagnostic value of early pulmonary bacterial infection[J].Henan Med Res,2021,30(6):1122-1124.
[5] 韩志梅.痰液标本细菌培养及药敏试验对下呼吸道感染用药的指导作用[J].中国老年保健医学,2021,19(1):129-131.
HAN Z M.The influence of bacterial culture and susceptibility test results of sputum specimens on the rational use of antibiotics in elderly patients with lower respiratory tract infection[J].Chin J Geriatr Care,2021,19(1):129-131.
[6] 尹琳琳,朱一堂,王文龙.降钙素原、C反应蛋白、血清淀粉样蛋白A在儿童细菌性与非细菌性医院获得性肺炎中的鉴别诊断价值[J].医学综述,2022,28(2):406-410,416.
YIN L L,ZHU Y T,WANG W L.Value of procalcitonin,C-reactive pronein,and serum amyloid A protein in differential diagnosis of bacterial and non-bacterial hospital-acquired pneumonia in children[J].Med Recapit,2022,28(2):406-410,416.
[7] 李学群.改进痰培养标本采集方法对细菌学检验质量的影响[J].护理与康复,2010,9(3):253-254.
LI X Q.Effect of improving sputum culture specimen collection method on bacteriological test quality[J].J Nurs Rehabil,2010,9(3):253-254.
[8] 刘晓琳,刘丹丹.痰涂片与细菌培养对痰标本的筛查结果及病原学特点[J].临床医学研究与实践,2021,6(33):118-120.
LIU X L,LIU D D.Screening results and etiological characteristics of sputum specimens by sputum smear and bacterial culture[J].Clin Clin Res Pract,2021,6(33):118-120.
[9] 何敏霞,宛传丹,戈惠丽,等.临床呼吸道感染细菌培养检验中涂片镜检技术的病原学诊断价值研究[J].医学检验与临床,2022,33(1):39-42.
HE M X,WAN C D,GE H L,et al.Research on the etiological diagnostic value of smear microscopy in bacterial culture examination of clinical respiratory tract infection[J].Med Lab Sci Clin,2022,33(1):39-42.
[10] 尚红,王毓三,申子瑜.全国临床检验操作规程[M].北京:人民卫生出版社,2015:594-608,648-725.
SHANG H,WANG Y S,SHEN Z Y.National guide to clinical laboratory procedures[M].Beijing:People′s Medical Publishing House,2015:594-608,648-725.
[11] 王云花.小儿细菌性肺炎的病原菌及其耐药性分析[J].中国现代药物应用,2014,12:12-14.
WANG Y H.Analysis of pathogens and drug resistance of pediatric bacterial pneumonia[J].Chin J Mod Drug Appl,2014,12:12-14.
[12] 闫宇娇,王德莉,石对先.儿童细菌性重症肺炎病原菌分布、耐药性分析及临床用药指导[J].中国药物滥用防治杂志,2021,27(3):398-401.
YAN Y J,WANG D L,SHI D X.Distribution drug resistance and clinical medication guidance of pathogens in children with severe bacterial pneumonia[J].Chin J Drug Abuse Prevent Treat,2021,27(3):398-401.
[13] 叶伟强,曾庆栈.重症细菌性肺炎患者病原菌分布与抗菌类药物使用相关性分析[J].黑龙江医药,2021,34(3):592-595.
YE W Q,ZENG Q Z.Correlation analysis between the distribution of pathogenic bacteria and the use of antibacterial drugs in patients with severe bacterial pneumonia[J].Heilongjiang Med J,2021,34(3):592-595.
[14] 赵永娟,陈志营,何罗玮,等.卒中相关性肺炎病原菌分布及耐药性分析[J].中国实验诊断学,2022,26(4):538-542.
ZHAO Y J,CHEN Z Y,HE L W,et al.Distribution and drug resistance of pathogenic bacteria in stroke associated pneumonia[J].Chin J Lab Diagn,2022,26(4):538-542.
[15] 唐雯娟,谢兰,罗林凤.呼吸道感染患者产超广谱β-内酰胺酶大肠埃希菌、肺炎克雷伯菌检测及耐药性分析[J].标记免疫分析与临床,2020,27(3):393-397.
TANG W J,XIE L,LUO L F.The detection and drug resistance analysis of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in patients with respiratory tract infection[J].Labeled Immunoass Clin Med,2020,27(3):393-397.
[16] 丁风琴,马翠萍,左兴智,等.11249株临床分离革兰氏阴性杆菌耐药性分析[J].宁夏医学杂志,2018,4(6):522-525.
DING F Q,MA C P,ZUO X Z,et al.Analysis of drug resistance of 11249 clinical isolated gram-negative bacteria[J].Ningxia Med J,2018,4(6):522-525.
[17] 韩新田,郝宇.基层医院院内呼吸道感染铜绿假单胞菌及鲍曼不动杆菌耐药谱分析[J].临床医学研究与实践,2018,3(15):50-51,76.
HAN X T,HAO Y.Analysis on drug resistance of Pseudomonas aeruginosa and Acinetobacter baumannii of patients with hospital acquired respiratory infection in primary hospital[J].Clin Res Pract,2018,3(15):50-51,76.
[18] 李光灿,王红苹,程林,等.2017—2019年重庆某三甲医院细菌耐药监测分析[J].安徽医药,2022,26(7):1474-1479.
LI G C,WANG H P,CHENG L,et al.Monitoring and analysis of bacterial resistance in a tertiary hospital in Chongqing from 2017 to 2019[J].Anhui Med Pharmac J,2022,26(7):1474-1479.
[19] 唐燕.万古霉素与去甲万古霉素对老年感染患者的肾毒性对比评价[J].健康必读,2021(8):243,246.
TANG Y.Comparative evaluation of nephrotoxicity of vancomycin and norvancomycin in elderly patients with infection[J].Healthmust-Readmag,2021(8):243,246.
[20] 陈智鸿,吕晓菊.金黄色葡萄球菌耐药性监测[J].中国抗感染化疗杂志,2003,3(1):13-15.
CHEN Z H,LV X J.Antimicrobial resistance of Staphylococcus aureus[J].China J Infect Chemother,2003,3(1):13-15.
[21] 张光莉.儿童金黄色葡萄球菌肺炎的临床特点及耐药性分析[D].重庆:重庆医科大学,2014.
ZHANG G L.Clinical characteristics and drug resistance of Staphylococcus aureus in children[D].Chongqing:Chongqing Medical University,2014.